I'm not going to call Larry, because he just tells people what they want to hear. That's pointless. This could potentially be a tough 5 years, particularly with FIO and possible ALR going away, and HIV/Syph pushed into 2016. I'm not sure why the BOD would refuse reasonable offers given the long, long road ahead.
If it isn't the Head Cheerleader, Mo. Why don't you call your BFF LS and tell how how the mean, mean people on yahoo are hurting your feelings. Loser.
I expressly forbid any of The Cheerleaders to read any of my posts or act on any of the highly useful information contained therein. If you're A Cheerleader, please put me on ignore. Oh, and BTW, you're most trusted source LS, paragon of truth, told you one to two weeks almost three weeks ago now. He's not particularly credible at this point. Every time he talks, the stock takes a hit. The market can't wait to see him exit the building.
I must be writing really interesting stuff if The Cheerleaders want it banned. The Cheerleaders might become upset if Score or I write something which doesn't support The Narrative. Poor babies. Such delicate sensibilities.
Misstep? The FDA letter makes clear that there had been dozens of contacts over four years and the company did absolutely nothing. Unbelievable arrogance. As to OSUR, the management should be sacked immediately. First, they bought a company the business of which was totally dependent on a company which was out of compliance. Did OSUR enquire as to FDA status of test kit? This is gross incompetence on the part of OSUR management. The lawsuits are coming. This could get really ugly for OSUR management. Tremendous opportunity for CEMI to run between the tackles on DPP HIV...if they can ever get the product waived.
One other thing: this is a firing offence for OSUR CEO, as far as I'm concerned. Given the other poor decisions made by OSUR management, he should be shown the door. How will this impact CEMI? Probably not a whole lot, although OSUR could attempt a desperation takeover of CEMI in order to distract investors. Perhaps OSUR will lose focus if management changes occur, which would benefit DPP HIV.
BTW: still waiting for CLIA application PR. Does LS consult with his regulatory people before telling investors "a week or two"? I'm an advocate for getting the application right before submission, but why make promises which you'll break. He should have said end of November or end of year.
I'm glad the FDA has the integrity to act against a company controlled by Sergey Brin's wife. I guess OSUR figured that 23andMe had a "Google Put" as far as the FDA was concerned, because anyone with even a modicum of exposure to FDA rules would understand that 23andMe was selling a medical device without approval. I guess the FDA isn't as subject to political influence as most of the rest of the economy. Yeah!
OSUR bought the company which produces the collection kits for 23andMe, DNA Genotek. Now, that business will be sidelined until 23andMe gets FDA approval. OSUR paid $53 million for Genotek. Yikes. Should have bought CEMI instead.
The so-called Palestinians only care about one thing: killing Jews and wiping Israel off the face of the map. Whatever money they receive winds up in PA "leader" bank accounts, or is used to fund terror and reward terrorists. These oil and gas finds will make Israel much more able to withstand the Muslim Arab onslaught. Listen, why don't you just give up? Nothing you do will defeat Israel. None of your Jihads will defeat Israel, which grows stronger economically, militarily and demographically each year. Give it up.
It's not going to be easy to dislodge Oraquick. Going to be a long, tough battle. Sales will rise only slowly. If they sell $2 million in 2014, that would be commendable.
The potential acquirers leaked this information last year. I didn't make it up. It was going to be around $3.30, and Ferro said no. I seriously doubt he'd get that right now. So, they're forced to attempt a turnaround or sell assets. However, since everyone's aware of MRGE's dire predicament, I doubt prices offered for assets would be very high.
My question is, whether or not Dearborn is competent to turn this around, he's going to have Ferro interfering every step up the way. "Hey, Justin, what about kiosks! Hey, Justin, we should have a game room and an ice cream parlour. Hey, Justin, we should move all the employees to Chicago!" Hard to run things effectively in that situation.
That's a very good observation. They need money to license antigens and reagents and money to develop the products and money to run the various trials. A bigger company would have the resources to undertake all these efforts simultaneously. CEMI has to do it in sequence. Had the FDA not dropped the hammer on Syph/HIV, I think they'd be doing that and HCV right now, and we'd be looking at HCV by 2015.
As I've said for some time, DPP is worth much more in the hands of a resource rich company since they'd be able to develop a wider variety of products more quickly. This isn't anyone's "fault" in particular. It's just a fact of life for a small company. LS attempted to sell the company a couple of years ago. Don't know what was offered and don't know if offers would be higher today.
As to ALR, they're a $3 billion revenue company. They probably sell around $20-$25 million of Clearview product. That's less than 1%. Don't think they spend much time thinking about CEMI. However, if they owned CEMI, they'd have the Clearview money plus half of OSUR's $35 million oral fluid market (we're up to $40 of US revenue alone), plus another $10 million of international revenue (at least). So, that's $50 million of revenue right off the bat. Plus, they'd be able to run trials on DPP for every disease under the sun, human and animal, simultaneously. DPP could be a $100 million product within 3 years and $200 million within 5 years for ALR. At the standard 3x revenues, CEMI is worth $600 million within 5 years. Not bad considering they could get it for $100 million or less right now.
Please. No one can partner with Ferro. Did you read the recent article in Chicago magazine. The guy is, to be polite, not normal. He makes a complete mess of everything. Merge has no chance so long as he's involved.
What this company hasn't been able to do is to get products to market in a timely manner. As we've seen with Syph/HIV, the FDA is a bear. Sure, it would be great id CEMI added a new product to the US market every year. Not gonna happen.